DK1392830T3 - Interleukin-18 mutanter, deres fremstilling og anvendelse - Google Patents
Interleukin-18 mutanter, deres fremstilling og anvendelseInfo
- Publication number
- DK1392830T3 DK1392830T3 DK02758668T DK02758668T DK1392830T3 DK 1392830 T3 DK1392830 T3 DK 1392830T3 DK 02758668 T DK02758668 T DK 02758668T DK 02758668 T DK02758668 T DK 02758668T DK 1392830 T3 DK1392830 T3 DK 1392830T3
- Authority
- DK
- Denmark
- Prior art keywords
- mutants
- interleukin
- preparation
- molecule
- wild type
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27432701P | 2001-03-08 | 2001-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1392830T3 true DK1392830T3 (da) | 2006-05-08 |
Family
ID=23047735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02758668T DK1392830T3 (da) | 2001-03-08 | 2002-03-08 | Interleukin-18 mutanter, deres fremstilling og anvendelse |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7524488B2 (da) |
| EP (1) | EP1392830B1 (da) |
| JP (1) | JP2004530432A (da) |
| KR (1) | KR100862136B1 (da) |
| CN (1) | CN100503829C (da) |
| AT (1) | ATE315647T1 (da) |
| AU (1) | AU2002324249B2 (da) |
| BR (1) | BRPI0207933B8 (da) |
| CA (1) | CA2438851C (da) |
| DE (1) | DE60208692T2 (da) |
| DK (1) | DK1392830T3 (da) |
| EA (1) | EA005769B1 (da) |
| ES (1) | ES2251610T3 (da) |
| HK (1) | HK1084151A1 (da) |
| IL (2) | IL157800A0 (da) |
| MX (1) | MXPA03008110A (da) |
| SI (1) | SI1392830T1 (da) |
| UA (1) | UA79235C2 (da) |
| WO (1) | WO2002101049A2 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004031341D1 (de) | 2003-07-21 | 2011-03-24 | Transgene Sa | Multifunktionelle cytokine |
| CA2531773A1 (en) * | 2003-07-21 | 2005-02-17 | Transgene S.A. | Novel multifunctional cytokines |
| SI1689777T1 (sl) * | 2003-11-05 | 2007-08-31 | Ares Trading Sa | Postopek za äśiĺ äśenje il-18 vezavnega proteina |
| WO2005097998A2 (en) * | 2004-03-31 | 2005-10-20 | Regeneron Pharmaceuticals, Inc. | Il-18 specific polypeptides and therapeutic uses thereof |
| WO2006128908A1 (en) | 2005-06-03 | 2006-12-07 | Ares Trading S.A. | Production of recombinant il-18 binding protein |
| EP1891088B1 (en) | 2005-06-10 | 2011-10-19 | Ares Trading S.A. | Process for the purification of il-18 binding protein |
| CN101177454B (zh) * | 2007-05-09 | 2010-09-22 | 郑骏年 | Il-18突变体多肽及制备及用途 |
| WO2012078936A2 (en) * | 2010-12-10 | 2012-06-14 | Glaxosmithkline Llc | Methods to produce a purified peptide chain fraction |
| CA3080492A1 (en) * | 2017-09-06 | 2019-03-14 | Yale University | Interleukin-18 variants and methods of use |
| JP2021170968A (ja) * | 2020-04-22 | 2021-11-01 | 国立大学法人 長崎大学 | マウスｉｌ−１８の製造方法及びそのための組換えｄｎａ |
| KR20230052956A (ko) * | 2020-08-19 | 2023-04-20 | 브라이트 피크 테라퓨틱스 아게 | 변형된 il-18 폴리펩티드 및 이의 용도 |
| IL302517A (en) | 2020-11-02 | 2023-07-01 | Simcha Il 18 Inc | Variants of interleukin-18 and methods of use |
| JPWO2022172944A1 (da) * | 2021-02-10 | 2022-08-18 | ||
| US20230146665A1 (en) | 2021-07-27 | 2023-05-11 | Xencor, Inc. | Il-18-fc fusion proteins |
| JP2023024168A (ja) | 2021-08-06 | 2023-02-16 | 国立大学法人 長崎大学 | がんの治療剤 |
| WO2023056193A2 (en) * | 2021-09-29 | 2023-04-06 | Chimera Bioengineering, Inc. | Il-18 variants and uses thereof |
| WO2023118497A1 (en) * | 2021-12-22 | 2023-06-29 | Pieris Pharmaceuticals Gmbh | Novel il-18 variants |
| WO2023161854A1 (en) * | 2022-02-23 | 2023-08-31 | Bright Peak Therapeutics Ag | Immune antigen specific il-18 immunocytokines and uses thereof |
| US20230357342A1 (en) * | 2022-02-23 | 2023-11-09 | Bright Peak Therapeutics Ag | Modified il-18 polypeptides |
| WO2023161853A1 (en) | 2022-02-23 | 2023-08-31 | Bright Peak Therapeutics Ag | Activatable il-18 polypeptides |
| WO2024044780A1 (en) * | 2022-08-26 | 2024-02-29 | Sutro Biopharma, Inc. | Interleukin-18 variants and uses thereof |
| WO2024102693A2 (en) | 2022-11-07 | 2024-05-16 | Xencor, Inc. | Il-18-fc fusion proteins |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4024366B2 (ja) * | 1996-11-29 | 2007-12-19 | 株式会社林原生物化学研究所 | ポリペプチド |
| TWI227136B (en) * | 1998-05-21 | 2005-02-01 | Smithkline Beecham Corp | Novel pharmaceutical composition for the prevention and/or treatment of cancer |
| IL129427A0 (en) | 1999-04-13 | 2000-02-17 | Yeda Res & Dev | Preparation of biologically active molecules |
-
2002
- 2002-03-08 DE DE60208692T patent/DE60208692T2/de not_active Expired - Lifetime
- 2002-03-08 WO PCT/IB2002/002344 patent/WO2002101049A2/en active IP Right Grant
- 2002-03-08 JP JP2003503799A patent/JP2004530432A/ja active Pending
- 2002-03-08 US US10/094,153 patent/US7524488B2/en not_active Expired - Lifetime
- 2002-03-08 IL IL15780002A patent/IL157800A0/xx unknown
- 2002-03-08 BR BRPI0207933-0 patent/BRPI0207933B8/pt not_active IP Right Cessation
- 2002-03-08 CA CA2438851A patent/CA2438851C/en not_active Expired - Lifetime
- 2002-03-08 SI SI200230280T patent/SI1392830T1/sl unknown
- 2002-03-08 CN CNB02809803XA patent/CN100503829C/zh not_active Expired - Lifetime
- 2002-03-08 EA EA200300987A patent/EA005769B1/ru not_active IP Right Cessation
- 2002-03-08 AU AU2002324249A patent/AU2002324249B2/en not_active Expired
- 2002-03-08 ES ES02758668T patent/ES2251610T3/es not_active Expired - Lifetime
- 2002-03-08 EP EP02758668A patent/EP1392830B1/en not_active Expired - Lifetime
- 2002-03-08 MX MXPA03008110A patent/MXPA03008110A/es active IP Right Grant
- 2002-03-08 KR KR1020037011581A patent/KR100862136B1/ko active IP Right Grant
- 2002-03-08 AT AT02758668T patent/ATE315647T1/de active
- 2002-03-08 DK DK02758668T patent/DK1392830T3/da active
- 2002-08-03 UA UA2003109084A patent/UA79235C2/uk unknown
-
2003
- 2003-09-08 IL IL157800A patent/IL157800A/en unknown
-
2006
- 2006-06-06 HK HK06106439.0A patent/HK1084151A1/xx not_active IP Right Cessation
-
2009
- 2009-03-16 US US12/404,458 patent/US7875709B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1392830B1 (en) | 2006-01-11 |
| IL157800A0 (en) | 2004-03-28 |
| ATE315647T1 (de) | 2006-02-15 |
| AU2002324249B2 (en) | 2007-04-05 |
| BR0207933A (pt) | 2004-03-02 |
| KR20030088448A (ko) | 2003-11-19 |
| CA2438851A1 (en) | 2002-12-19 |
| HK1084151A1 (en) | 2006-07-21 |
| BRPI0207933B1 (pt) | 2020-11-24 |
| JP2004530432A (ja) | 2004-10-07 |
| DE60208692T2 (de) | 2006-07-13 |
| US20020169291A1 (en) | 2002-11-14 |
| CN1764723A (zh) | 2006-04-26 |
| BRPI0207933B8 (pt) | 2021-05-25 |
| DE60208692D1 (de) | 2006-04-06 |
| CA2438851C (en) | 2011-07-26 |
| IL157800A (en) | 2009-08-03 |
| MXPA03008110A (es) | 2003-12-12 |
| US7875709B2 (en) | 2011-01-25 |
| WO2002101049A2 (en) | 2002-12-19 |
| ES2251610T3 (es) | 2006-05-01 |
| EP1392830A2 (en) | 2004-03-03 |
| EA200300987A1 (ru) | 2004-02-26 |
| US7524488B2 (en) | 2009-04-28 |
| CN100503829C (zh) | 2009-06-24 |
| SI1392830T1 (sl) | 2006-06-30 |
| EA005769B1 (ru) | 2005-06-30 |
| UA79235C2 (en) | 2007-06-11 |
| WO2002101049A3 (en) | 2003-12-18 |
| US20090286855A1 (en) | 2009-11-19 |
| KR100862136B1 (ko) | 2008-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1392830T3 (da) | Interleukin-18 mutanter, deres fremstilling og anvendelse | |
| NO20042418L (no) | Anti-IL-6-antistoffer, sammensetninger, fremgangsmater og deres anvendelser | |
| ATE449840T1 (de) | Alpha-amylasevariante mit veränderten eigenschaften | |
| DE50208842D1 (de) | Federelement | |
| MA30153B1 (fr) | Anticorps anti-ox40l et methodes correspondantes | |
| MXPA03010909A (es) | Derivados de epotilona. | |
| MXPA04012614A (es) | Xilanasas, acidos nucleicos que las codifican, y metodos para hacerlas y usarlas. | |
| ATE469911T1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| ATE304866T1 (de) | Chelatorkonjugate mit verbesserten eigenschaften | |
| WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
| WO2002053104A3 (en) | Use of catecholamine reuptake inhibitors to enhance memory | |
| IL175646A0 (en) | Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof | |
| DK1339853T3 (da) | Isolerede luciferaser og deres anvendelse | |
| SG146640A1 (en) | Isolated photoprotein mtclytin, and use thereof | |
| DE60330116D1 (de) | Aus fisch gewonnene peptide und nukleinsäuren der cathelicidin familie und deren verwendung | |
| CY1109904T1 (el) | Προαγωγεας της il-18bp, η παρασκευη και χρηση του | |
| DK1005532T3 (da) | Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf | |
| AU2003259750A8 (en) | Methods and compositions for targeting secretory lysosomes | |
| NO20042768L (no) | IFNAR2 mutanter, deres fremstilling og anvendelse | |
| ES2192034T3 (es) | Feniluracilos substituidos con efecto herbicida. | |
| WO2002063013A3 (en) | Human acid phosphatase gene | |
| WO2001064840A8 (en) | Novel bone marrow nucleic acids and polypeptides | |
| TW200640945A (en) | Mutants of the fluorescent protein CGFP, and their use | |
| BR8201310U (pt) | Estofados de estrutura metálica | |
| SE0100412D0 (sv) | Novel human poly(A) polymerase |